title: As the inflammatory nature of chronic rhinosinusitis (CRS) has become increasingly recognized, the use of steroids, both systemic and topical, as part of the disease management has significantly increased.
authors.forename: David W
authors.initials: DW
authors.lastname: Kennedy
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000818:Animals; D002277:Carcinoma; D002908:Chronic Disease; D005357:Fibrous Dysplasia of Bone / Q000175:diagnosis; D006801:Humans; D051379:Mice; D055556:Nasal Lavage; D009298:Nasal Polyps / Q000188:drug therapy / Q000378:metabolism; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000601:surgery; D009668:Nose Diseases / Q000188:drug therapy* / Q000378:metabolism; D010000:Osteitis / Q000382:microbiology; D010016:Osteoma / Q000175:diagnosis; D012220:Rhinitis / Q000188:drug therapy / Q000378:metabolism; D016879:Salvage Therapy / Q000379:methods; D012852:Sinusitis / Q000188:drug therapy / Q000378:metabolism; D012886:Skull / Q000033:anatomy & histology / Q000601:surgery; D013100:Sphenoid Bone / Q000382:microbiology; D019966:Substance-Related Disorders / Q000150:complications
chemical_list: D000305:Adrenal Cortex Hormones